The US Food and Drug Administration granted an Emergency Use Authorization for Pfizer and BioNTech's SARS-CoV-2 vaccine on Friday, as the New York Times reports.
The US Food and Drug Administration granted an Emergency Use Authorization for Pfizer and BioNTech's SARS-CoV-2 vaccine on Friday, as the New York Times reports.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.